USP14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.021600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.426200E-01
Normal-vs-Stage2
7.626000E-01
Normal-vs-Stage3
8.745400E-01
Normal-vs-Stage4
6.650600E-01
Stage1-vs-Stage2
6.109800E-01
Stage1-vs-Stage3
8.949400E-01
Stage1-vs-Stage4
5.423600E-01
Stage2-vs-Stage3
5.634800E-01
Stage2-vs-Stage4
6.130800E-01
Stage3-vs-Stage4
5.956200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.080000E-01
Normal-vs-AfricanAmerican
3.857200E-01
Normal-vs-Asian
8.428600E-01
Caucasian-vs-AfricanAmerican
4.065200E-01
Caucasian-vs-Asian
4.302000E-01
AfricanAmerican-vs-Asian
1.935960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.851200E-01
Normal-vs-Female
6.947800E-01
Male-vs-Female
3.747600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.623000E-01
Normal-vs-Age(41-60Yrs)
3.479800E-01
Normal-vs-Age(61-80Yrs)
9.167200E-01
Normal-vs-Age(81-100Yrs)
8.619600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.437800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.659600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.475600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.10380000000333E-05
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.257900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.565200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.988800E-01
Normal-vs-Daily Drinker
5.711800E-01
Normal-vs-Weekly Drinker
7.244000E-01
Normal-vs-Occasional Drinker
6.072200E-01
Normal-vs-Social Drinker
5.442600E-01
Non Drinker-vs-Daily Drinker
3.316800E-01
Non Drinker-vs-Weekly Drinker
3.674600E-01
Non Drinker-vs-Occasional Drinker
1.759200E-01
Non Drinker-vs-Social Drinker
1.438620E-01
Daily Drinker-vs-Weekly Drinker
1.145420E-01
Daily Drinker-vs-Occasional Drinker
4.772300E-02
Daily Drinker-vs-Social Drinker
4.001800E-02
Weekly Drinker-vs-Occasional Drinker
7.284800E-01
Weekly Drinker-vs-Social Drinker
6.374600E-01
Occasional Drinker-vs-Social Drinker
8.959200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.333600E-01
Normal-vs-Grade 2
1.412400E-01
Normal-vs-Grade 3
1.499010E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.934430E-01
Grade 1-vs-Grade 3
1.368020E-01
Grade 1-vs-Grade 4
3.333600E-01
Grade 2-vs-Grade 3
5.826400E-01
Grade 2-vs-Grade 4
1.412400E-01
Grade 3-vs-Grade 4
1.499010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.443200E-01
Normal-vs-NonDiabetic
8.061200E-01
Diabetic-vs-NonDiabetic
1.729750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.434000E-01
Normal-vs-NoPancreatitis
8.385600E-01
Pancreatitis-vs-NoPancreatitis
9.021200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.013400E-01
Normal-vs-N1
7.766400E-01
N0-vs-N1
9.177200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.218800E-01
Normal-vs-TP53-NonMutant
8.805600E-01
TP53-Mutant-vs-TP53-NonMutant
1.635510E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
